Gain Therapeutics, Inc. (GANX)

Gain Therapeutics, Inc. in the Healthcare sector is trading at $1.32 with a market capitalization of $75M. Wall Street consensus targets $7.20 (5 analysts), implying a +445.5% move over the next 12 months. The stock is currently near its 52-week low of $1.29, remaining 32.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. Risk note: RSI 11 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.